Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

1.30
-0.0500-3.70%
Post-market: 1.30-0.0010-0.08%19:30 EDT
Volume:1.13M
Turnover:1.48M
Market Cap:100.97M
PE:-2.20
High:1.38
Open:1.36
Low:1.26
Close:1.35
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:0.68
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:3.81
PE(LYR):-1.89

Loading ...

Cardiff Oncology Shares Rise After Upgrade From HC Wainwright

MT Newswires Live
·
Sep 16

Cardiff Oncology Price Target Announced at $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 15

HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9

MT Newswires Live
·
Sep 15

Cardiff Oncology, Inc. : H.c. Wainwright Raises to Buy from Neutral

THOMSON REUTERS
·
Sep 15

Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright

TIPRANKS
·
Sep 15

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)

TIPRANKS
·
Sep 14

Cardiff Oncology - no Admission of Liability or Monetary Payment in Cardiff-Nerviano Settlement - SEC Filing

THOMSON REUTERS
·
Sep 14

Cardiff Oncology, Nerviano Settle Onvansertib Rights Lawsuit, Seek Dismissal with Prejudice

Reuters
·
Sep 14

Cardiff Oncology, - Co and Nms Agree to Full Mutual Release of All Claims in Litigation

THOMSON REUTERS
·
Sep 14

Cardiff Oncology and Nerviano Medical Sciences Amend Their 2017 Exclusive License Agreement

THOMSON REUTERS
·
Sep 14

Cardiff Oncology to Present at RAS-Targeted Drug Development Summit

Reuters
·
Sep 02

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 27

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 15

Replimune Q1 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

MT Newswires Live
·
Aug 12

Cardiff Oncology, Inc. : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Aug 12